The powers of participatory medicine
- PMID: 24736935
- PMCID: PMC3987994
- DOI: 10.1371/journal.pbio.1001837
The powers of participatory medicine
Abstract
Does participatory medicine always empower patients, or could it also serve as a tool to shift responsibilities from other actors to individual patients?
Conflict of interest statement
The author has declared that no competing interests exist.
References
-
- FDA (2013) 23andMe, Inc. 11/22/13. Available: http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm37629.... Accessed 17 February 2014.
-
- Conley J (5 December 2013) The revolt of the Cs: class action filed against 23andMe. Genomics Law Report. Available: http://www.genomicslawreport.com/index.php/2013/12/05/the-revolt-of-the-.... Accessed 17 February 2014.
-
- Sterckx S, Cockbain J, Howard HC, Borry P (2013) “I prefer a child with…”: designer babies, another controversial patent in the arena of direct-to-consumer genomics. Genet Med 15: 923–924. - PubMed
-
- Prainsack B (8 October 2013) 23andMe's “designer baby” patent: when corporate governance and open science collide. Genomes Unzipped Available: http://www.genomesunzipped.org/2013/10/guest-post-23andmes-designer-baby.... Accessed 17 February 2014.
-
- Frydman G (2013) A patient-centric definition of participatory medicine. Available: http://participatorymedicine.org/epatients/2010/04/a-patient-centric-def.... Accessed 17 February 2014.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources